What is JSPR's dilution risk score?

JSPR has a latest available DilutionScore record of 65/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for JSPR, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for JSPR?

DilutionWatch tracks 25 SEC filing types for JSPR including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect JSPR shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For JSPR, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for JSPR tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for JSPR. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

JSPR Dilution Risk Score: 65/100 (HIGH)

Score Breakdown

📋 Offering Ability

52

💰 Cash Runway

95

📊 Float Risk

30

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

⛈️

Warning

High probability of dilution event

model est. 53%

🔄 Reverse Split model est. 70%

• 50-day avg $0.93 below $1 exchange minimum

• Only 2 months cash — financial pressure

💰 Capital Raise model 55%

• Critical: only 2.0 months cash remaining

📉 Score Deterioration model 10%

• Score in HIGH risk zone (65/100)

🔔 Track JSPR — Get forecast alerts →

Market Data

Market Cap$23.21M

Shares Outstanding33.27M

Float21.88M

Cash$10.71M

Debt$757.0K

Short InterestN/A

Institutional Holdings

QoQ: ↑ 7.5% shares (2026Q1 vs prior)

65 institutional holders · 21.76M shares

#1 MORGAN STANLEY 4.09M shares

#2 Velan Capital Investment Management LP 2.67M shares

#3 VANGUARD CAPITAL MANAGEMENT LLC 2.35M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest4.31M

Days to Cover1.0

% of Float19.7%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual JSPR Dilution Snapshot

Jasper Therapeutics, Inc. (JSPR) has a DilutionScore of 65/100, rated High dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for JSPR: xbrl on 2025-12-31.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.